XML 24 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Note 5 - Stockholders' Equity and Common Stock Warrants
9 Months Ended
Sep. 30, 2021
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]

5.

Stockholders' Equity and Common Stock Warrants

 

February 2021 Common Stock Offering

 

In February 2021, the Company completed the February 2021 Offering in which it offered and sold 33,658,538 shares of its common stock in an underwritten, public offering for a purchase price to the public of $1.025 per share, inclusive of shares offered and sold pursuant to the exercise-in-full by the underwriter of its 30-day option to purchase additional shares. The February 2021 Offering resulted in aggregate net proceeds to the Company of $31.1 million, after deducting underwriting commissions, discounts, and expenses but prior to deducting other offering costs. In addition, at the closings of the February 2021 Offering, the Company issued to designees of the underwriter of the transaction warrants to purchase up to an aggregate of 1,682,927 shares of common stock to designees. The underwriter warrants have an exercise price of $1.28125 per share and a term of five years from the date of issuance.

 Common Stock Warrants

 

As of September 30, 2021, the Company had the following warrants outstanding to acquire shares of its common stock:

   

Outstanding

   

Range of exercise

price per share

   

Expiration dates

Common stock warrants issued in 2017 related to Series A convertible preferred stock offering

    903,870       $33.30      

March 2022

Common stock warrants issued in 2018 related to the January 2018 Offering

    1,181,421    

$12.00

- $15.00    

January 2023

Common stock warrants issued related to the May 2019 Offering

    1,382,913    

$5.00

- $6.11875    

May and December 2024

Common stock warrants issued related to the November 2019 Offering

    213,570       $0.35      

November 2024

Common stock warrants issued related to the December 2019 Offering

    313,339    

$0.4335

- $0.6981    

December 2024 and June 2025

Common stock warrants issued related to the May 2020 Offering

    571,429       $1.31      

May 2025

Common stock warrants issued related to May 2020 Investor Warrant Exercise

    250,000       $0.5938      

November 2025

Common stock warrants issued related to the February 2021 Offering

    1,682,927       $1.28      

February 2026

      6,499,469                

 

During the nine months ended September 30, 2021, 53,570 warrants expired and 4,230,000 warrants were exercised for aggregate proceeds of approximately $2.2 million.